Compared to the WT control, CD68‐IBA1 immunoreactivity was significantly elevated in the PRh region of vehicle‐treated AD mice at both 10 and 16 weeks (p < 0.02 and 0.03, respectively; Figure 5B,b1). This evidence concerns the gene AIF1 and Alzheimer disease.